Development of immunotherapeutic immunizations for virus infections and cancer by Frazer, Ian
DEVELOPMENT OF IMMUNOTHERAPEUTIC IMMUNIZATION FOR VIRUS INFECTIONS AND CANCER 
 




Key Words: Immunotherapy, Cell mediated immunity, Viruses, Cancer 
 
Vaccines to prevent virus infection have generally been successful in preventing epidemic childhood infections. 
However, immunization to resolve persisting viral infection or to eradicate cancer cells expressing non-self 
antigen has proven challenging when naturally induced immune responses have proven insufficient.  In many 
clinical trials, only minimal efficacy has been demonstrated.  We have used animal models of persisting infection 
to study better immunotherapy strategies. In a model of Herpes Simplex infection, infection can be controlled by 
inducing immune responses in skin rather than muscle, and by biasing those responses to favor T cell 
responses over antibody, enabling clearance of otherwise lethal infection. In a model of persisting infection with 
papillomavirus, we have shown that hyper proliferative epithelium expressing papillomavirus proteins secretes 
cytokines attracting immunoregulatory lymphocytes, and these suppress cytotoxic T cell responses.  Local 
immunosuppression can be overcome by removing inhibitory cytokines, by administering checkpoint blockade 
inhibitors, or by preventing epithelial proliferation and consequent attraction of regulatory cells. Clinical trials 
based on these findings, planned or underway, will be discussed.   
 
 
